These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 22426487)
1. Serum HE4 concentration is not dependent on menstrual cycle or hormonal treatment among endometriosis patients and healthy premenopausal women. Hallamaa M; Suvitie P; Huhtinen K; Matomäki J; Poutanen M; Perheentupa A Gynecol Oncol; 2012 Jun; 125(3):667-72. PubMed ID: 22426487 [TBL] [Abstract][Full Text] [Related]
2. [The values of serum human epididymis secretory protein 4 and CA(125) assay in the diagnosis of ovarian malignancy]. Dong L; Chang XH; Ye X; Zhu LR; Zhao Y; Tian L; Cheng HY; Li XP; Zhang H; Liao QP; Fu TY; Cheng YX; Cui H Zhonghua Fu Chan Ke Za Zhi; 2008 Dec; 43(12):931-6. PubMed ID: 19134334 [TBL] [Abstract][Full Text] [Related]
3. [Diagnostic value of combining detection of human epididymis protein 4 and CA125 in patients with malignant ovarian carcinoma]. Wang MJ; Qi J; Wang H; Li XX; Wei BJ; Fu C; Gao J; Han BB Zhonghua Zhong Liu Za Zhi; 2011 Jul; 33(7):540-3. PubMed ID: 22093635 [TBL] [Abstract][Full Text] [Related]
4. Differences in the blood serum levels of soluble HLA-G concentrations between the menstrual cycle phases and menopause in patients with ovarian endometriosis and uterine leiomyoma. Basta P; Mach P; Pitynski K; Bednarek W; Klimek M; Zietek J; Zajac K; Wicherek L Neuro Endocrinol Lett; 2009 Mar; 30(1):91-8. PubMed ID: 19300397 [TBL] [Abstract][Full Text] [Related]
5. Comparison of ovarian cancer markers in endometriosis favours HE4 over CA125. Mckinnon B; Mueller MD; Nirgianakis K; Bersinger NA Mol Med Rep; 2015 Oct; 12(4):5179-84. PubMed ID: 26165164 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of HE4 as an extrabiomarker to CA125 to improve detection of ovarian carcinoma: is it time for a step forward? Azzam AZ; Hashad DI; Kamel NA Arch Gynecol Obstet; 2013 Jul; 288(1):167-72. PubMed ID: 23361457 [TBL] [Abstract][Full Text] [Related]
7. Comparison between Serum HE4 and CA125 as Tumor Markers in Premenopausal Women with Benign Pelvic Mass. Huang X; Wang Y; He X; Kang F; Luo L; Su Z; Ye H Clin Lab; 2019 May; 65(5):. PubMed ID: 31115211 [TBL] [Abstract][Full Text] [Related]
8. [Clinical value of combined detection of serum human epididymal secretory protein E4 and CA(125) in the diagnosis of endometrial carcinoma]. Zhang AM; Zhang P Zhonghua Fu Chan Ke Za Zhi; 2012 Feb; 47(2):125-8. PubMed ID: 22455745 [TBL] [Abstract][Full Text] [Related]
9. Use of CA125 fluctuation during the menstrual cycle as a tool in the clinical diagnosis of endometriosis; a preliminary report. Kafali H; Artuc H; Demir N Eur J Obstet Gynecol Reprod Biol; 2004 Sep; 116(1):85-8. PubMed ID: 15294374 [TBL] [Abstract][Full Text] [Related]
10. Serum concentrations of HE4 change little during in vitro fertilization. Hallamaa M; Huhtinen K; Suvitie P; Perheentupa A Acta Obstet Gynecol Scand; 2014 Jul; 93(7):640-6. PubMed ID: 24734893 [TBL] [Abstract][Full Text] [Related]
11. [Measurement of serum human epididymis secretory protein 4 combined with CA125 assay in differential diagnosis of endometriosis cyst and ovarian benign and malignant tumors]. Liu YN; Ye X; Cheng HY; Cheng YX; Fu TY; Chen J; Chang XH; Cui H Zhonghua Fu Chan Ke Za Zhi; 2010 May; 45(5):363-6. PubMed ID: 20646446 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of erythrocyte band 3 phosphotyrosine level, glutathione content, CA-125, and human epididymal secretory protein E4 as combined parameters in endometriosis. Bordin L; Fiore C; Donà G; Andrisani A; Ambrosini G; Faggian D; Plebani M; Clari G; Armanini D Fertil Steril; 2010 Oct; 94(5):1616-21. PubMed ID: 20153468 [TBL] [Abstract][Full Text] [Related]
13. Is HE4 a useful endometrioma marker? Leggieri C; D'Agostino G; Tommasi L; Plebani M; Conte L Eur J Gynaecol Oncol; 2014; 35(4):438-41. PubMed ID: 25118488 [TBL] [Abstract][Full Text] [Related]
14. The clinical significance of the combined detection of serum Smac, HE4 and CA125 in endometriosis-associated ovarian cancer. Xu XR; Wang X; Zhang H; Liu MY; Chen Q Cancer Biomark; 2018 Feb; 21(2):471-477. PubMed ID: 29226858 [TBL] [Abstract][Full Text] [Related]
15. CA125 and HE4 levels in a Czech female population diagnosed with endometrial cancer in preoperative management. Presl J; Novotny Z; Topolcan O; Vlasak P; Kucera R; Fuchsova R; Vrzalova J; Betincova L; Svobodova S Anticancer Res; 2014 Jan; 34(1):327-31. PubMed ID: 24403483 [TBL] [Abstract][Full Text] [Related]
16. The effect of the phase of the menstrual cycle and the birth control pill on athletic performance. Lebrun CM Clin Sports Med; 1994 Apr; 13(2):419-41. PubMed ID: 8013042 [TBL] [Abstract][Full Text] [Related]
17. [HE4--a new tumor marker for ovarian cancer]. Manolov V; Marinov B; Vasilev V; Andreeva A Akush Ginekol (Sofiia); 2011; 50 Suppl 2():11-5. PubMed ID: 22524132 [TBL] [Abstract][Full Text] [Related]
18. Afamin and apolipoprotein A-IV: novel protein markers for ovarian cancer. Dieplinger H; Ankerst DP; Burges A; Lenhard M; Lingenhel A; Fineder L; Buchner H; Stieber P Cancer Epidemiol Biomarkers Prev; 2009 Apr; 18(4):1127-33. PubMed ID: 19336561 [TBL] [Abstract][Full Text] [Related]
19. Alterations in RCAS1 serum concentration levels during the normal menstrual cycle and the lack of analogical changes in ovarian endometriosis. Wicherek L Am J Reprod Immunol; 2008 Jun; 59(6):535-44. PubMed ID: 18422812 [TBL] [Abstract][Full Text] [Related]
20. Human epididymis protein 4 offers superior specificity in the differentiation of benign and malignant adnexal masses in premenopausal women. Holcomb K; Vucetic Z; Miller MC; Knapp RC Am J Obstet Gynecol; 2011 Oct; 205(4):358.e1-6. PubMed ID: 21722869 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]